Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with Fosigotifator
Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with Fosigotifator
Sean M. Healey & AMG Center Announces Update in ALS Platform Trial with Fosigotifator
Sean M. Healey & AMG Center Announces Topline Results in HEALEY ALS Platform Trial with eIF2B Agonist DNL343
After a diagnosis of non-small cell lung cancer, Flora McCoy-Greene sought the latest treatment from an integrated cancer care team at Mass General. Read her story.
Researchers found that genetic swaps in the gut microbiome are occurring much more frequently than previously thought and detected more than 100,000 swaps that hadn’t been seen before.
Jordan Ball, MS, RD shares a recipe for a winter vegetable sheet pan dinner.
Understanding the power of balanced, whole foods and adopting mindful eating habits is the true foundation for a healthy lifestyle that lasts beyond January 31st. Learn more.
Mass General Brigham is proud to announce the award of $6 million to 35 organizations dedicated to improving both mental and behavioral health outcomes, as well as promoting economic mobility and financial stability in the communities we serve.
University of Minnesota, Essentia Health Dose First Participants in Sean M. Healey & AMG Center for ALS, Never Surrender Inc. Led Expanded Access Protocol Programs
A panel of sustainability experts discuss the environmental impacts of the health care system and ways to reduce it.
Shadmehr (Shawn) Demehri, MD, PhD, of the Department of Dermatology and Center for Cancer Immunology at Massachusetts General Hospital, is the corresponding author of a paper published in Cancer Cell, “Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin.”
Members of the media can reach the media relations team by email or phone.